Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age-Reference-Cited by-同舟云学术

Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age

Published:2009-12 Issue:1 Volume:28 Page:71-78
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Prymula Roman,Kriz Pavla,Kaliskova Eva,Pascal Thierry,Poolman Jan,Schuerman Lode

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference49 articles.

1. Pneumococcal vaccine: clinical efficacy and effectiveness;Schwartz;Ann Intern Med,1982

2. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children;Black;Pediatr Infect Dis J,2000

3. Efficacy of a pneumococcal conjugate vaccine against acute otitis media;Eskola;N Engl J Med,2001

4. Haemophilus influenzae a significant pathogen in acute otitis media;Leibovitz;Pediatr Infect Dis J,2004

5. Distribution of protein D, an immunoglobulin D-binding protein, in Haemophilus strains;Akkoyunlu;Infect Immun,1991

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trend change of nasopharyngeal colonization with Streptococcus pneumoniae and non-typeable Haemophilus influenzae in children attending daycare centres: nationwide population-based study, South Korea 2014 and 2019;International Journal of Infectious Diseases;2021-10

2. Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial;Vaccine: X;2021-04

3. Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial;Vaccine;2021-04

4. Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation;Expert Review of Vaccines;2019-06-03

5. PCV7- and PCV10-Vaccinated Otitis-Prone Children in New Zealand Have Similar Pneumococcal and Haemophilus influenzae Densities in Their Nasopharynx and Middle Ear;Vaccines;2019-01-31